Yeonghwan Kim
Overview
Explore the profile of Yeonghwan Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
449
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang C, Kim J, Ryu J, Kim Y, Ahn S, Choi S
World Neurosurg
. 2022 Jan;
161:e90-e100.
PMID: 35077893
Objective: Patients who experience vertebral compression fractures are vulnerable to subsequent vertebral compression fractures (SVCFs). The purpose of this nationwide population-based study was to determine the age-specific cumulative incidence and...
2.
Zhang H, Kim Y, Ro E, Ho C, Lee D, Trapp B, et al.
J Neurosci
. 2019 Nov;
40(2):447-458.
PMID: 31719166
Cognitive impairments are key features in multiple sclerosis (MS), a progressive disorder characterized by neuroinflammation-induced demyelination in the central nervous system. To understand the neural substrates that link demyelination to...
3.
Lee Y, Kim K, Kim D, Cho H, Kim Y, Rheey J, et al.
PLoS One
. 2015 Oct;
10(10):e0137703.
PMID: 26444992
Glioblastoma (GBM) is the most aggressive and most lethal brain tumor. As current standard therapy consisting of surgery and chemo-irradiation provides limited benefit for GBM patients, novel therapeutic options are...
4.
Sa J, Yoon Y, Kim M, Kim Y, Cho H, Lee J, et al.
Oncotarget
. 2015 May;
6(24):20145-59.
PMID: 26023737
Glioblastoma (GBM) is the most lethal brain cancer with profound genomic alterations. While the bona fide tumor suppressor genes such as PTEN, NF1, and TP53 have high frequency of inactivating...
5.
Feng X, Szulzewsky F, Yerevanian A, Chen Z, Heinzmann D, Rasmussen R, et al.
Oncotarget
. 2015 May;
6(17):15077-94.
PMID: 25987130
The most abundant populations of non-neoplastic cells in the glioblastoma (GBM) microenvironment are resident microglia, macrophages and infiltrating monocytes from the blood circulation. The mechanisms by which monocytes infiltrate into...
6.
Wang L, Soe N, Sowden M, Xu Y, Modjeski K, Baskaran P, et al.
Thromb Haemost
. 2014 Jan;
111(5):873-82.
PMID: 24429998
Cyclophilin A (CyPA) is an important mediator in cardiovascular diseases. It possesses peptidyl-prolyl cis-trans isomerase activity (PPIase) and chaperone functions, which regulate protein folding, intracellular trafficking and reactive oxygen species...
7.
Soe N, Sowden M, Baskaran P, Kim Y, Nigro P, Smolock E, et al.
Cardiovasc Res
. 2013 Dec;
101(3):444-53.
PMID: 24293519
Aims: Cyclophilin A (CyPA) is a pro-inflammatory mediator involved in oxidative stress-related cardiovascular diseases. It is secreted from vascular smooth muscle cell (VSMC) in response to reactive oxygen species (ROS)...
8.
Soe N, Sowden M, Baskaran P, Smolock E, Kim Y, Nigro P, et al.
Arterioscler Thromb Vasc Biol
. 2013 Jul;
33(9):2147-53.
PMID: 23846495
Objective: Angiotensin II (AngII) signal transduction in vascular smooth muscle cells (VSMC) is mediated by reactive oxygen species (ROS). Cyclophilin A (CyPA) is a ubiquitously expressed cytosolic protein that possesses...
9.
Jang M, Kim Y, Won H, Lim S, K R J, Dashdorj A, et al.
Cancer Res
. 2012 Jun;
72(16):4214-24.
PMID: 22719067
Arsenic trioxide (As2O3) is used, in current practice, as an effective chemotherapeutic agent for acute promyelocytic leukemia (APL). However, the side effects and relatively low efficacy of As2O3 in treating...
10.
Lim S, Rashid M, Jang M, Kim Y, Won H, Lee J, et al.
Cell Physiol Biochem
. 2011 Dec;
28(5):873-86.
PMID: 22178940
Mitochondrial oxidative damage is thought to play a key role in pancreatic β-cell failure in the pathogenesis of type 2 diabetes. Despite this, the potential of mitochondria-targeted antioxidants to protect...